Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Observation of Momelotinib Effectiveness in Myelofibrosis (ROME)

NCT07249606 is registered in ClinicalTrials.gov with Gruppo Italiano Malattie EMatologiche dell'Adulto as lead sponsor.

NCT NCT07249606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07249606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Observation of Momelotinib Effectiveness in Myelofibrosis (ROME)
Lead sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase
Observational
Overall status
Not yet recruiting
Start date
January 2, 2026
Completion date
April 2, 2028
Enrollment
93 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myelofibrosis (mf)